Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.47
1.44%
After-hours: Aug 15, 2025, 07:52 PM EDT
Cardiff Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M | -6.76M | -5.18M |
Depreciation & Amortization | 229K | 228K | 96K | 101K | 105K | 102K | 103K | 107K | 98K | 90K | 86K | 81K | 38K | 31K | 113K | 110K | 109K | 119K |
Stock-Based Compensation | 1.68M | 1.36M | 1.2M | 1.25M | 1.18M | 1.12M | 909K | 955K | 1.58M | 1.06M | 1.01M | 1.04M | 1.05M | 1.15M | 990K | 940K | 1.04M | 268K |
Other Working Capital | n/a | -1.18M | 532K | 370K | 776K | -109K | 3.39M | 925K | 976K | 1.27M | -2.86M | -7K | 1.18M | -1.04M | -524K | -836K | 99K | -128K |
Other Non-Cash Items | 3.7M | -137K | -158K | -157K | 647K | -138K | -21.64M | 9.73M | 11.15M | -163K | -39K | 115K | 211K | 485K | 527K | 579K | 546K | 380K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 21.43M | -10.04M | -11.39M | n/a | n/a | n/a | n/a | n/a | 442K | 450K | 433K | -2K |
Change in Working Capital | n/a | -816K | 378K | 202K | 1.39M | 1.2M | 1.39M | 1.02M | 2.58M | 1.57M | -1.75M | -148K | 2.44M | -924K | -20K | -631K | 332K | -1.47M |
Operating Cash Flow | -8.33M | -12.79M | -10.27M | -10.46M | -9.23M | -7.74M | -7.14M | -7.96M | -7.13M | -8.66M | -9.39M | -7.49M | -6.7M | -10.25M | -7.39M | -5.46M | -4.3M | -5.88M |
Capital Expenditures | -26K | n/a | n/a | n/a | n/a | -80K | -8K | -315K | -251K | -8K | -75K | -448K | -312K | -171K | -107K | -98K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 6.77M | 315K | 251K | -7.34M | -7.09M | n/a | n/a | n/a | -98K | n/a | n/a | n/a |
Purchase of Investments | -20.89M | -34.91M | n/a | -22.64M | n/a | -919K | -2.59M | -16.62M | -13.54M | -37.33M | -10.8M | -23.12M | -20.54M | -36.77M | -27.75M | -4.68M | -27.75M | -114.19M |
Sales Maturities Of Investments | 15.03M | 21.23M | 4.51M | 13.21M | 14.02M | 5.63M | 16.16M | 20.76M | 25.28M | 44.66M | 17.9M | 28.69M | 28.39M | 55.3M | 19.07M | 12.83M | 8.75M | 2.5M |
Other Investing Acitivies | 902K | -902K | n/a | n/a | 14.02M | 4.72M | -6.77M | -315K | -251K | 7.34M | 7.09M | 43K | 71K | 18.53M | 98K | -98K | -19M | -111.7M |
Investing Cash Flow | -4.98M | -14.58M | 4.51M | -9.43M | 14.02M | 4.64M | 13.56M | 3.82M | 11.48M | 7.33M | 7.02M | 5.16M | 7.61M | 18.36M | -8.79M | 8.05M | -19M | -111.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | -6K | -6K | n/a | -12K | -6K | -6K | n/a | -414K | -6K | -6K | -6K | -24K | n/a | n/a | -6K |
Other Financial Acitivies | n/a | 3K | 13K | 7.43M | 2.06M | 107K | n/a | 6K | 6K | n/a | 414K | 75K | 6K | 6K | n/a | n/a | n/a | 1.26M |
Financial Cash Flow | n/a | 3K | 44.19M | 7.43M | 2.06M | 107K | 12K | -6K | -6K | n/a | n/a | 75K | -6K | -6K | 14.96M | n/a | 19.23M | 1.26M |
Net Cash Flow | -13.31M | -27.38M | 38.43M | -12.46M | 6.84M | -3M | 6.42M | -4.14M | 4.35M | -1.33M | -2.37M | -2.25M | 913K | 8.11M | -1.22M | 2.58M | -4.08M | -116.32M |
Free Cash Flow | -8.35M | -12.79M | -10.27M | -10.46M | -9.23M | -7.82M | -7.15M | -8.27M | -7.38M | -8.67M | -9.46M | -7.93M | -7.01M | -10.42M | -7.5M | -5.56M | -4.3M | -5.88M |